Literature DB >> 11766955

Physical performance and health-related quality of life in men on a liver transplantation waiting list.

G F Wiesinger1, M Quittan, K Zimmermann, M Nuhr, M Wichlas, M Bodingbauer, R Asari, G Berlakovich, R Crevenna, V Fialka-Moser, M Peck-Radosavljevic.   

Abstract

Twenty-six men on a liver transplant waiting list (12 had alcoholic cirrhosis, 8 suffered from posthepatitic cirrhosis, and 6 from cirrhosis of other etiologies) were eligible for this observation. Nineteen subjects underwent exercise testing to determine oxygen uptake at anaerobic threshold. In all patients dynamometry was performed to determine isokinetic muscle strength of knee extensor muscles, and handgrip. Quality of life was evaluated in all patients with the MOS SF-36 questionnaire. Child-Pugh A patients showed 54 +/- 8%, Child-Pugh B patients 36 +/- 2%, and Child-Pugh C patients 31 +/- 4% of VO2 max predicted at the anaerobic threshold (Kruskal-Wallis ANOVA, p < 0.05). Isokinetic muscle strength of the quadriceps femoris (left/right) was 149 +/- 20/134 +/- 14 Nm in Child-Pugh A, 108 +/- 16/114 +/- 19 Nm in Child-Pugh B, and 89 +/- 10/81 +/- 11 Nm in Child-Pugh C patients (Kruskal-Wallis ANOVA, p < 0.05). MOS-SF36 revealed a Child-Pugh class dependent reduced functional status (Kruskal-Wallis ANOVA, p < 0.05). No significant differences in target parameters were found when analysed according to the etiology of cirrhosis. Patients on the liver transplant waiting list do have a stage dependent reduction in physical health. These data are the basis for longitudinal studies measuring the effects of preoperative rehabilitation programs in these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11766955     DOI: 10.1080/165019701753236446

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  12 in total

1.  Exercise manual for liver disease patients.

Authors:  Vivian Limongi; Daniele Costa Dos Santos; Aurea Maria de Oliveira da Silva; Ilka de Fátima Santana Ferreira Boin; Raquel Silveira Bello Stucchi
Journal:  World J Transplant       Date:  2016-06-24

2.  Who is willing to take the risk? Assessing the readiness for living liver donation in the general German population.

Authors:  F C Popp; N Eggert; L Hoy; S A Lang; A Obed; P Piso; H J Schlitt; M H Dahlke
Journal:  J Med Ethics       Date:  2006-07       Impact factor: 2.903

Review 3.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

4.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

5.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

6.  Six Minute Walk Test to assess functional capacity in chronic liver disease patients.

Authors:  Hatem F Alameri; Faisal M Sanai; Manal Al Dukhayil; Nahla A Azzam; Khalid A Al-Swat; Ahmad S Hersi; Ayman A Abdo
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

Review 7.  Preoperative optimization for major hepatic resection.

Authors:  Sarah Walcott-Sapp; Kevin G Billingsley
Journal:  Langenbecks Arch Surg       Date:  2017-11-18       Impact factor: 3.445

Review 8.  Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?

Authors:  Guido Stirnimann; Maryam Ebadi; Puneeta Tandon; Aldo J Montano-Loza
Journal:  Curr Gastroenterol Rep       Date:  2018-09-26

9.  Metabolic syndrome after liver transplantation: preventable illness or common consequence?

Authors:  Eric R Kallwitz
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

10.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.